CAPITAL STOCK AND ADDITIONAL PAID IN CAPITAL | 5. CAPITAL STOCK AND ADDITIONAL PAID IN CAPITAL The holders of common stock are entitled to one vote for each share held. There are no restrictions that limit the Company’s ability to pay dividends on its common stock. The Company has not declared any dividends since incorporation. The Company’s common stock has no par value per common share. During the three months ended March 31, 2023, there were no share issuances pursuant to private placements. During the year ended December 31, 2022, the Company issued 37,803,218 units as part of a private placement valued at CAD$0.09 per unit. Each unit consists of one common share and one share purchase warrant. Each warrant will entitle the holder thereof to purchase one common share in the capital of the Company at an exercise price of CAD$0.1075 at any time up to 5 years following the date of issuance. The warrants attached to the private placement are classified as a derivative liability at an initial value of $1,781,779. During the three months ended March 31, 2023 no stock options were exercised. During the year ended December 31, 2022, the holders of 900,000 stock options exercised their options for 900,000 shares for $106,989 (CAD$135,000) at an exercise price of CAD$0.15 per share.. Warrants A summary of warrant activity for the quarter ended March 31, 2023, is as follows: Number of warrants Exercise price Expiry date Outstanding December 31, 2022 - - - Granted 37,803,218 CAD$0.1075 May 20 - June 14, 2027 Outstanding March 31, 2023 37,803,218 CAD$0.1075 A fair value of the derivative liability of $1,781,779 was estimated on the date of the subscription using the Black-Scholes pricing model. A fair value of the derivative liability of $1,194,885 was estimated at December 31, 2022 using the Black-Scholes pricing mode. For the quarter ended March 31, 2023, there was a non-cash gain on derivative liability – warrants of $429,806 and an unrealized foreign exchange loss of $22,129 resulting in a fair value as at March 31, 2023 of $787,208 with the following weighted average assumptions: March 31, 2023 Issuance date Exercise price CAD$0.1075 CAD$0.1075 Stock price CAD$0.05 CAD$0.09 Expected term 4.25 years 5 years Expected dividend yield - - Expected stock price volatility 94.26 % 85.69 % Risk-free interest rate 4.50 % 2.73 % Stock Options The Company established a stock option plan (the “Plan”) under which it is authorized to grant options to executive officers and directors, employees and consultants. The number of options granted under the Plan shall not exceed 15% of the shares outstanding. Under the Plan, the exercise period of the options may not exceed ten years from the date of grant and vesting is determined by the Board of Directors. Stock option transactions are summarized as follows: Stock Options Number Weighted average exercise price in Canadian $ Outstanding, December 31, 2021 34,615,000 $ 0.18 Granted 5,700,000 0.09 Exercised 900,000 ) 0.15 Expired (3,535,000 ) 0.37 Outstanding, December 31, 2022 34,665,000 0.14 Expired (5,700,000 ) 0.23 Outstanding, March 31, 2023 28,965,000 $ 0.12 Number currently exercisable 26,115,000 $ 0.12 As at March 31, 2023, incentive stock options were outstanding as follows: Number of Options Outstanding Number of Options Exercisable Exercise Price in Canadian $ Expiry Date Options 350,000 350,000 0.185 August 30, 2023 3,240,000 3,240,000 0.150 May 9, 2024 50,000 50,000 0.130 June 24, 2024 7,450,000 7,450,000 0.065 March 19, 2025 100,000 100,000 0.075 May 22, 2025 5,900,000 5,900,000 0.140 November13, 2025 6,175,000 6,175,000 0.180 May 23, 2026 5,700,000 2,850,000 0.090 June 24, 2027 28,965,000 26,115,000 As at March 31, 2023 the Company’s outstanding and exercisable stock options have an aggregate intrinsic value of $Nil (December 31, 2021 - $Nil). |